Natalie C. Manalo

TL;DR: The use of consumer-targeted wearable and mobile sleep monitoring technology has largely focused on validation of devices and applications compared with polysomnography but opportunities exist for observational research and for delivery of behavioral interventions.

TL;DR: The use of wearable sleep tracking devices is rapidly expanding and provides an opportunity to engage individuals in monitoring of their sleep patterns as mentioned in this paper, and there are a growing number of patients who are seeking treatment for self-diagnosed sleep disturbances such as insufficient sleep duration and insomnia due to periods of light or restless sleep observed on their sleep tracker data.

TL;DR: In this paper, the authors conducted a systematic review of studies conducted in adult populations that used consumer sleep tracking technology to deliver sleep-related interventions and found that wearable devices are being used for two main purposes: 1) to deliver treatment for insomnia and 2) sleep monitoring as part of overall wellness programs.

TL;DR: Whether supplemental exposure to bright white light will reduce MS-associated fatigue is investigated to provide a low-cost, noninvasive, self-administered treatment for one of the most prevalent and burdensome symptoms experienced by people with MS.

TL;DR: LT is safe, feasible, and well-tolerated in people with MS-associated fatigue and improvement in both light spectra likely indicates a strong placebo effect for the DRLT group.